SC pushes for tighter rules on pharma freebies to doctors. The Supreme Court on Thursday directed the Centre to form a three-member panel to examine how drugmakers market medicines to doctors and suggest whether statutory rules are needed. The move could lead to legally enforceable rules on freebies, gifts and benefits offered to doctors by pharmaceutical companies. The petition argues such incentives may influence prescriptions and raise patient costs.